Tài liệu Báo cáo khoa học: Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides docx

In particular, I focus on the relative contributions of intracellular targeting and membrane disruption to the overall killing strategy of antimicrobial peptides, as well as on mechanism

Multifunctional host defense peptides:

intracellular-targeting antimicrobial peptides

Pierre Nicolas

Biogene`se des Signaux Peptidiques, ER3-UPMC, Universite´ Pierre et Marie Curie, Paris, France

Introduction

There has been increasing interest in recent years in

describing the complex, multifunctional role that

anti-microbial peptides play in directly killing microbes,

boosting specific inate immune responses, and exerting

selective immunomodulatory effects on the host [1–4] Furthermore, many antimicrobial peptides are quite inactive on normal eukaryotic cells The basis for this discrimination appears to be related to the lipid

com-Keywords

antimicrobial peptides; cell-penetrating

peptides; dermaseptin; intracellular target;

membrane translocation

Correspondence

P Nicolas, Biogene`se des Signaux

Peptidiques (BIOSIPE), ER3-UPMC,

Universite´ Pierre et Marie Curie, Baˆtiment A

– 5e`me e´tage, Case courrier 29, 7 Quai

Saint-Bernard, 75005 Paris, France

Fax: +1 44 27 59 94

Tel: +1 44 27 95 36

E-mail: pierre.nicolas@upmc.fr

(Received 1 May 2009, revised 25 July

2009, accepted 29 July 2009)

doi:10.1111/j.1742-4658.2009.07359.x

There is widespread acceptance that cationic antimicrobial peptides, apart from their membrane-permeabilizing⁄ disrupting properties, also operate through interactions with intracellular targets, or disruption of key cellu-lar processes Examples of intracellucellu-lar activity include inhibition of DNA and protein synthesis, inhibition of chaperone-assisted protein folding and enzymatic activity, and inhibition of cytoplasmic membrane septum formation and cell wall synthesis The purpose of this minireview

is to question some widely held views about intracellular-targeting anti-microbial peptides In particular, I focus on the relative contributions of intracellular targeting and membrane disruption to the overall killing strategy of antimicrobial peptides, as well as on mechanisms whereby some peptides are able to translocate spontaneously across the plasma membrane Currently, there are no more than three peptides that have been convincingly demonstrated to enter microbial cells without the involvement of stereospecific interactions with a receptor⁄ docking mole-cule and, once in the cell, to interfere with cellular functions From the limited data currently available, it seems unlikely that this property, which is isolated in particular peptide families, is also shared by the hun-dreds of naturally occurring antimicrobial peptides that differ in length, amino acid composition, sequence, hydrophobicity, amphipathicity, and membrane-bound conformation Microbial cell entry and⁄ or membrane damage associated with membrane phase⁄ transient pore or long-lived transitions could be a feature common to intracellular-targeting antimi-crobial peptides and mammalian cell-penetrating peptides that have an overrepresentation of one or two amino acids, i.e Trp and Pro, His, or Arg Differences in membrane lipid composition, as well as differential lipid recruitment by peptides, may provide a basis for microbial cell kill-ing on one hand, and mammalian cell passage on the other

Abbreviations

MIC, minimal inhibitory concentration; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol.

position of the target membrane (i.e fluidity, negative

charge density, and the absence⁄ presence of

choles-terol), and the possession, by the microbial organism,

of a large, negative transmembrane electrical potential

There is now a widespread acceptance that

antimicro-bial peptides, apart from their

membrane-permeabiliz-ing⁄ disrupting properties, may also affect microbial

viability by interactions with intracellular targets or

disruption of key intracellular processes Much of the

focus in this area has been on the identification of

tar-gets in the interior of the microbial cell and the

mecha-nism by which antimicrobial peptides can enter the

microbial cell in a nondisruptive way [5–7]

The prevailing dogma that the microbicidal effects

of cationic antimicrobial peptides solely involve

cyto-plasmic membrane permeabilization⁄ disruption of

target cells has been increasingly challenged by the

realization that: (a) information on the membrane

interactions and activity of antimicrobial peptides

obtained in vitro using simple artificial membrane

bilayers, or in vivo using intact microbial cells, is not

clearly correlated with the observation of microbial

death; (b) several antimicrobial peptides may recognize

and inactivate cellular targets in vitro, such as nucleic

acids, proteins, enzymes, and organelles, their

mecha-nism of action being postulated to involve

transloca-tion across the plasma membrane in a nonlethal

manner; (c) regardless of which model of antimicrobial

peptide-induced membrane permeabilization⁄ disruption

is correct, they all offer the peptide the possibility of

rapidly crossing the cytoplasmic membrane and

reach-ing macromolecular targets in the cell interior; and (d)

most antimicrobial peptides show strong similarities in

charge, structure and membrane interactions with

cell-penetrating peptides, which are thought to enter

mam-malian cells by passive transport [8] The purpose of

this minireview is to describe and critically analyze

some widely held views about intracellular-targeting

antimicrobial peptides In particular, I focus on the

proposed mechanisms by which antimicrobial peptides

might translocate across microbial membranes to

attack cellular targets

Microbial membrane permeabilization

versus intracellular killing

There has been increasing speculation in the last

dec-ade that antimicrobial peptide-mediated

permeabiliza-tion⁄ disruption of the microbial cytoplasmic

membrane is not the only mechanism of cell killing,

and that antimicrobial peptide might also operate by

entering the cells and interfering with their metabolic

function

Antimicrobial peptides with varying antimicrobial potencies exhibit disparate extents of membrane permeabilization and cell killing

Even though all cationic antimicrobial peptides are able to interact with microbial cytoplasmic mem-branes, and some strongly perturb bilayers, the num-ber of studies documentating a clear dissociation between cell death and the ability of some peptides to permeabilize the membrane, either in vitro or in vivo, has increased significantly during the last decade For example, TWF, an analog of the cathelicidin-derived antimicrobial peptide tritrpticin, in which Trp is replaced with Phe, is much more effective than TPA,

in which the two Pro residues of tritrpticin are replaced with with Ala, against both Staphylococ-cus aureus and Escherichia coli [9] However, TWF shows very little membrane-disrupting activity and no ability to depolarize the membrane potential of micro-bial cell targets, whereas TPA rapidly depolarizes the membrane and causes rapid leakage of negatively charged phospholipid vesicles Dermaseptin B2 – GLWSKIKEVGKEAAKAAAKAAGKAALGAVSE-AVa – from frog skin and its C-terminally truncated analog [1–23]-dermaseptin B2 are both highly effective

in permeabilizing calcein-loaded phosphatidylcholine (PC)⁄ phosphatidylglycerol (PG) and phosphatidyletha-nolamine (PE)⁄ PG vesicles [10] Whereas dermaseptin B2 rapidly kills bacteria [11], [1–23]-dermaseptin B2 is devoid of antimicrobial activity and is inefficient in permeating intact bacterial cells The bacterium-derived antimicrobial peptides polymyxin B and poly-mixin E1 failed to cause significant depolarization of the Pseudomonas aeruginosa cytoplasmic membrane but rapidly killed the test organism In contrast, grami-cidin S caused rapid depolarization of the bacterial cytoplasmic membrane at concentrations at which no killing was observed [12] These observations support the concept that, for some antimicrobial peptides, membrane perturbation and cell killing may be inde-pendent events that occur individually or complemen-tary to other mechanisms of action [13]

Antimicrobial peptides exhibit temporal dissociation between microbial membrane permeabilization and cell death

Although there is a wealth of evidence that many anti-microbial peptides interact and increase the permeabil-ity of microbial membranes as part of their killing mechanism, it is not clear whether this is a lethal step

In addition, several antimicrobial peptides kill

micro-bial cells in the absence of significant

permeabiliza-tion⁄ disruption of membrane structure and functions

[14] For some antimicrobial peptides, permeabilization

of the microbial cytoplasmic membrane and cell killing

begin concomitantly as quickly as a few minutes after

exposure [15–17] For others, there is a considerable

lag period between these two events For instance,

although TWF and TPA are equipotent in inhibiting

the growth of S aureus and E coli, TWF requires a

lag period of about 3–6 h for bactericidal activity,

whereas TPA kills bacteria after only after 30 min of

exposure [9] Experiments based on confocal

micros-copy on living cells using the fluorescence of

fluores-cein isothiocyanate, 4¢,6-diamidino-2-phenylindole and

5-cyano-2,3-ditolyl tetrazolium chloride revealed that

sublethal concentrations of temporin L permeabilize

the inner membrane of E coli to small compounds,

but do not allow the killing of bacteria [18] At higher

peptide concentrations, the bacterial membrane

becomes permeable to large cytoplasmic components,

and this is concomitant with death of bacteria This

shows that membrane permeabilization of bacteria by

temporin L and TWF is not a lethal step per se in the

absence of a catastrophic collapse of the membrane

integrity, and that peptide-mediated killing required

other additional events

The choice of a membrane model can

influence the outcome of an in vitro

study of lipid–peptide interaction

Most models accounting for antimicrobial

peptide-induced membrane permeabilization are inferred from

data obtained with very simple, artificial membrane

models that mimic microbial cell membranes, whether

in the form of lipid monolayers, oriented bilayers, or

vesicles (reviewed by Bhattacharjya and Ramamoorthy

[19]; this issue) Extrapolating these in vitro data to an

in vivomodel is not straightforward, and the choice of

the model system may profoundly influence the

out-come of a study of lipid–peptide interaction An

ele-gant study of the interaction of the human cathelicidin

antimicrobial peptide LL-37 with single phospholipid

monolayers, bilayers and bilayers composed of binary

mixtures of phospholipid species predominantly used

in model membrane experiments, i.e PC, PE, PG, and

phosphatidylserine, showed the following [20]: (a) the

effects on single lipid monolayers are not comparable

to those on the corresponding bilayers; (b) there are

four different modes of interaction of LL-37 on

bilay-ers with the four different lipids used; and (c) there are

significant differences in the mode of peptide–lipid

interaction between the binary lipid mixtures PC⁄ PG,

PE⁄ PG, and PC ⁄ phosphatidylserine, which all carry the same net charge A similar disagreement was observed for the interaction of dermaseptin B2 with cardiolipin⁄ PC and PG ⁄ PC vesicles

Peptide concentration dependence of antimicrobial action

Research on the mode of action of antimicrobial pep-tides in vitro has usually been conducted at high multi-ples of the minimal inhibitory concentration (MIC) of peptides and⁄ or high peptide ⁄ lipid ratios Owing to technical limitations, these high peptide concentrations are necessary to determine the three-dimensional struc-ture of membrane-bound antimicrobial peptides and to observe perturbation of the thermodynamic parameters

of the gel-to-crystalline phase transition of lipid mem-brane models, lipid flip-flop, calcein release on model liposomes, etc However, there is no evidence that such peptide concentrations, which provide almost full bac-terial membrane coverage by the peptides, are really present at the surface of bacteria during bacterial kill-ing in vivo [21] In addition, electron transport chains and ion and complex nutrient transport systems require the coordination over time and space of a net-work of interacting proteins, coenzymes, and sub-strates That microbial cell death may result from nonspecific interference of cationic amphipathic peptides with the dynamic organization of membrane-bound pathways rather than just from membrane permeabilization has seldom been evaluated, and it is hardly possible to do so in vitro through the use of lipid membrane models [22] The above-mentioned data collectively suggest that, at least near the MIC, the killing actions of some antimicrobial peptides are complex and may involve targets in the interior of the microbial cell

How antimicrobial peptides may enter microbial cells

Two general mechanisms are proposed to describe the process by which antimicrobial peptides enter the microbial cells, spontaneous lipid-assisted translocation and stereospecific receptor-mediated membrane trans-location The precise mechanisms whereby some antimicrobial peptides are able to translocate sponta-neously across the plasma membrane remain largely unknown, and may vary from peptide to peptide However, membrane translocation seems to be a corol-lary of transient membrane permeabilization There are currently several models accounting for antimicrobial

peptide-induced membrane permeabilization⁄ disruption

of microbial cells The Shai–Matzusaki–Huang unifying

model proposes that a-helical antimicrobial peptides

initially bind parallel to the membrane plane and

car-pet the surface of the bilayer [23–26], with the apolar

amino acids penetrating partly into the bilayer

hydro-carbon core, and the cationic residues interacting with

the negatively charged phosphate moieties of the lipid

head groups, hence causing membrane thinning and

positive curvature strain To release the strain, a

frac-tion of the peptides change their orientafrac-tion from

par-allel to transversal, forming transient mixed

phospholipid–peptide toroidal pores Upon

disintegra-tion of the pores, some peptides become translocated

to the inner leaflet of the membrane [27], suggesting

that stochastic pore disassembly may be a mechanism

by which antimicrobial peptides can reach the cell

inte-rior Note that only a few pores exist after the

redistri-bution of the peptides between the two leaflets,

because the pore formation is a cooperative process

Therefore, the integrity of the membrane is only

tran-siently breached, and pores are hardly detectable in the

equilibrium state by usual biophysical approaches

Once a threshold level of membrane-bound peptide is

reached, this may lead to disruption⁄ solubilization of

the membrane in a detergent-like manner The

thresh-old between the toroidal pore and the detergent-like

mechanisms of action may be related to two facets of

the cell killing mechanism relying on the peptide

con-centration: the membrane composition, and the final

peptide⁄ lipid ratio Because the threshold peptide

con-centrations required for membrane disruption are

always close to full bacterial membrane saturation,

doubts have arisen regarding the relevance of these

thresholds and their importance in vivo [21] However,

rigorous calculations have demonstrated that

antimi-crobial peptides with MIC values in the micromolar

range can easily reach millimolar concentrations in a

bacterial membrane, owing to high partition constants

[28] At this concentration level, there is a strong link

between cell death and membrane disruptive events

On the other hand, at low peptide⁄ lipid ratios,

antimi-crobial peptides may translocate across the plasma

membrane, perturbing its structure in a transient,

non-lethal manner, and reach the cell interior

Another mechanism for breaching membrane

perme-ability, the lipid phase boundary defects model,

pro-posed that some b-sheeted peptides, such as cateslytin,

a 15 residue Arg-rich antimicrobial peptide resulting

from the cleavage of chromogranin A, form mainly flat

aggregates at the surface of negatively charged

bacte-rial membranes as patches of antiparallel amphipathic

b-sheets forming rigid and thicker lipid domains

enriched in negatively charged lipids [29,30] These domains become ordered, mainly owing to the inser-tion of aromatic residues into the hydrophobic bilayer core Zones of different rigidity and thickness bring about phase boundary defects that lead to permeability induction and peptides crossing through bacterial membranes Thus, the peptides could pass through the membrane and interact with intracellular targets, as do other Arg-rich peptides (see below)

The disordered toroidal pore model proposed that a nanometer-sized, toroidal-shaped pore is formed by a single a-helical or b-sheeted peptide that is able to insert into the membrane, because of the difference in mechanical stress between the two faces of the mem-brane, and⁄ or because of the different electric field, i.e the electroporation-like mechanism [31–34] Above a threshold number of membrane-bound peptides, one peptide molecule becomes deeply embedded in the membrane interface The membrane–water interface becomes unstable, and solvent molecules from the pep-tide-free interface are able to interact with hydrophylic groups of the embedded peptide, resulting in the devel-opment of a continuous pore In contrast to the Shai– Matzusaki–Huang model of the toroidal pore, only one peptide is found near the center of the pore, and the remaining peptides lay close to the edge of the pore, maintaining a parallel orientation with respect to the membrane plane The resulting pore is sufficient to allow the passage of the peptide from one side of the membrane to the other A similar mechanism of tran-sient pore formation was proposed for the transloca-tion of the HIV-1 Tat cell-penetrating peptide across mammalian cell membranes [35]

Intracellular-targeting antimicrobial peptides

Although there is no doubt that most cationic antimi-crobial peptides act at high concentrations by permea-bilizing⁄ disrupting the microbial membrane, recent studies and reviews have reported an ever-growing list

of peptides that are presumed to affect microbial via-bility at low to moderate concentrations through inter-action with one or more intracellular targets (Table 1) Examples of intracellular activity include inhibition

of DNA and protein synthesis, inhibition of chaper-one-assisted protein folding, inhibition of enzymatic activity, and inhibition of cytoplasmic membrane sep-tum formation and cell wall synthesis Very different amounts of data, acquired with different experimental protocols, have been presented for individual peptides

in order to support this assumption, so that, in most cases, straightforward interpretation of these

RRIRPRPPRLPRPRPRPLPFPR P

F1

F0

Indolicidin [K6,8,9]-Indolicin

Tritrpticin TWF TPA

? ?

tions is difficult or, at best, arbitrary Representative

examples will be used to elaborate this issue, starting

with the more documented examples and moving

towards those that are less documented

Pro⁄ Arg-rich antimicrobial peptides

Pro⁄ Arg-rich antimicrobial peptides form a

heterolo-gous group of linear peptides isolated from mammals

and invertebrates that are predominantly active against

Gram-negative bacteria Members of this group include

pyrrhocoricin, drosocin and apidaecin from insects, and

the cathelicidin-derived peptides bactenecin, PR-39 and

prophenin from mammals [36] The mechanism of

action by which these peptides kill bacteria involve a

stereospecific interaction with a receptor⁄ docking

mole-cule that may be a component of a permease-type

transporter system on the inner membrane, followed by

translocation of the peptide into the interior of the cell

Once inside the cell, the peptides interact with the

tar-get, which, for pyrrhocoricin and drosocin, has been

clearly defined as the chaperone Dnak, or interfere with

DNA and protein synthesis through binding to nucleic

acids [37–39] Interestingly, Bac-7 has recently been

shown to inactivate bacteria via two different modes of

action, depending on its concentration: (a) at near-MIC

concentrations via stereospecific-dependent uptake that

is followed by its binding to an unknown intracellular

target, which may be DNA; and (b) at concentrations

higher than the MIC via a nonstereospecific

membran-olytic mechanism [40]

Histatin

Histatin-5 is a 24 residue, His-rich and weakly

aphi-pathic a-helical antimicrobial peptide found in human

salivary secretions that displays high candidacidal and

leishmanicidal activities at micromolar concentrations

Previous research has indicated that histatin-5 binds

heat shock protein 70 (Ssa1⁄ 2), located on the cell

wall, and is subsequently transferred to a membrane

permease that transports the peptide across to the

cytoplasm in a nonlytic manner [41] Ensuing studies

demonstrated that the uptake of histatin-5 is actually a

dichotomous event [42] Below the MIC, the peptide

translocates into the cytoplasm of the parasite through

receptor-mediated endocytosis (see above) and is

inter-nalized into the vacuole without harmful effects on the

parasite Under physiological concentrations, histatin-5

induces a concentration-dependent perturbation at a

spatially restricted site on the cell surface of Candida,

leading to rapid translocation of the peptide into the

cytoplasm in a nonstereospecific, receptor-independent

manner, causing only a fast but temporary depolariza-tion and limited damage to the plasma membrane, as shown by membrane depolarization, entrance of the vital dye SITOX green, electron microscopy, and time-lapse confocal microscopy on live cells Once inside the cell, the peptide accumulates in the mitochondrion, inducing bioenergetic collapse of the parasite, caused

by the decrease of mitochondrial ATP synthesis through inhibition of F1F0-ATPase Concurrent with the internalization and accumulation, rapid expansion

of the vacuole with a parallel loss of cell volume is observed, leading to cell death Histatin-5 shows poor translocation capacity in anionic liposomes The dependence of histatin-5 internalization on the membrane potential may provide an explanation for a single rupture per cell, rather than multiple breaches,

as once there is one site of leakage, the membrane potential is lost, and this prevents a second rupture

Buforin Buforin II is a 21 residue truncated analog of buforin

I, the histone H2A-derived antimicrobial peptide, which adopts a helix–hinge–helix structure in apolar media [43] Buforin II kills bacteria without lysing the cell membrane, even at five-fold the MIC It binds selectively to negatively charged liposomes, and trans-locates even below the MIC across artificial bilayers efficiently via the transient formation of toroidal pores, without inducing significant permeabilization or lipid flip-flop The induction of a positive curvature strain

by the peptide on the membrane is related to the trans-location process [44,45] Pro11 in the hinge region of the peptide plays a key role in the cell uptake mecha-nism by distorting the helix and concentrating basic residues in a limited amphipathic region, thus destabi-lizing the pore by electrostatic repulsion, enabling effi-cient translocation [46] Confocal laser fluorescence microscopy on living bacterial cells shows that, even below the MIC, the peptide penetrates the cell mem-brane and accumulates in the cytoplasm [47] Although buforin II was shown to bind DNA in vitro, the con-nection between nucleic acid binding and antimicrobial activity has not been demonstrated

Indolicidin Indolicidin is a Trp-rich, 13 residue antimicrobial peptide isolated from bovine neutrophils that adopts an extended wedge-type conformation when bound to biological membranes Owing to the presence of Trp residues interspersed with Pro residues throughout the sequence, it probably assumes a structure distinct from

the well-described helical and b-structured peptides.

Indolicidin is active against a wide range of

microorgan-isms, including bacteria, fungi, and protozoa, and lyses

erythrocytes Close to the MIC, indolicidin causes

sig-nificant membrane depolarization of the bacterial

cyto-plasmic membrane by forming transient pores, but does

not enter the cell and does not lead to cell wall lysis,

suggesting that there is more than one mechanism of

antimicrobial action [48] Earlier investigations have

shown that indolicidin mainly reduces the synthesis of

DNA, rather than RNA and protein, and that

inhibi-tion of DNA synthesis causes E coli filamentainhibi-tion and

contributes to the antimicrobial activity of indolicidin

[49] Unlike indolicidin, [K6,8,9]-indolicidin and

[K6,8,9,11]-indolicidin do not depolarize the membrane

and accumulate in the cytoplasm, as shown by confocal

laser microscopy on living E coli cells [50]

Gel-retarda-tion assays showed that [K6,8,9]-indolicidin and

[K6,8,9,11]-indolicidin bind strongly to DNA in vitro,

suggesting inhibition of intracellular functions via

inter-ference with DNA⁄ RNA synthesis Whether indolicidin

uses its membrane-binding properties to permeabilize

the cytoplasmic membrane, activate extracellular targets

or enter the cytoplasm and exert its antimicrobial

activ-ity by attacking intracellular targets is presently unclear

Magainin

Magainin-2, an a-helical peptide isolated from the

Afri-can clawed frog Xenopus laevis, forms toroidal transient

pores in the lipid bilayer of liposomes near the MIC,

inducing lipid flip-flop and the translocation of peptides

into the inner leaflet of the bilayer coupled to

mem-brane permeabilization Interaction of

F5W-magainin-2, an equipotent analog of magainin-F5W-magainin-2, with unfixed

Bacillus megaterium was investigated by confocal laser

microscopy [51] At four times the MIC, magainin-2

binds to bacteria, permeabilizes the cytoplasmic

mem-brane within seconds, and internalizes simultaneously

The influx of fluorescent markers of various size into

the cytosol revealed that magainin-2 permeabilizes the

bacterial membrane by forming toroidal pores with a

diameter of  2.8 nm However, there is no

informa-tion available from which to evaluate whether

magai-nin-2 disrupts key intracellular processes, and, if so, to

what extent this may contribute to its killing action

Polyphemusin

The horseshoe crab antimicrobial peptide

polyphe-musin I is a 18 amino acid peptide that is stabilized

into an amphipathic, antiparallel b-hairpin by two

disulfide bridges [52] It has excellent antimicrobial

activity against bacteria, demonstrating rapid killing within 5 min of treatment At two times the MIC, polyphemusin I is only able to depolarize the E coli cytoplasmic membrane by 50% [53] At the MIC, polyphemusin I is able to translocate through mem-brane bilayers of negatively charged model vesicles, inducing flip-flop between membrane leaflets Biotin-labeled polyphemusin I accumulates in the cytoplasm

of E coli within 30 min after addition, with only modest cytoplasmic membrane disruption, and causes disorganization of cytoplasmic structures [54] In these studies, permeabilization of E coli with Triton X-100 was performed after fixation with glutaraldehyde, so as

to allow streptavidin fluorescent conjugate to access intracellular biotin-labeled polyphemusin I Moreover, the mechanism of translocation and the nature of the intracellular targets are as yet undefined

Tachyplesin Tachyplesin I is a cyclic b-sheet antimicrobial peptide

of 17 amino acids isolated from the hemocytes of the horseshoe crab [55] The peptide forms transient pores

in membranes containing acidic phospholipids, and induces lipid flip-flop coupled to calcein leakage, the latter being coupled to the translocation of the peptide across lipid bilayers upon pore disintegration The pep-tide induced rapid inner membrane permeabilization of

E coli at MIC, concomitant with a rapid decrease of cell viability [56,57] Gel-retardation assays and foot-printing-like techniques using DNase I protection, dimethyl sulfate protection and bleomycin-induced DNA cleavage revealed that tachyplesin I interacts with the minor groove of the DNA duplex in vitro [58] It is not known yet whether tachyplesin I is able

to enter living cells, and whether its antibiotic activity

is due to its capacity to bind DNA or to depolarize the cytoplasmic membrane

Pleurocidin Pleurocidin and dermaseptins are a-helical antimicro-bial peptides isolated from winterflounder and frog skin, respectively When used at its MIC, the hybrid of pleurocidin and dermaseptin, P-der, inhibits E coli growth, but does not cause bacterial death within

30 min, and demonstrates a weak ability to permeabi-lize the bacterial membrane [59] When used at 10 times the MIC, the peptide causes rapid depolarization

of the cytoplasmic membrane and cell death, indicating that the cell membrane is a lethal target for the peptide applied at high concentrations Both sublethal and lethal concentrations of P-der inhibit macromolecular

synthesis within 5 min P-der is able to translocate

across the lipid bilayers of liposomes without causing

calcein leakage or flip-flop It has been proposed that

pleurocidin translocates in vitro from one side of the

membrane to another through disordered transient

pores, allowing the peptide to reach the cell interior

[60] As discussed above, membrane crossing remains

to be shown in living bacterial cells In addition, the

relative contributions of intracellular targeting and

membrane disruption to the overall killing strategy of

pleurocidin, as well as the precise mechanism by which

the peptide inhibits macromolecular synthesis in vivo,

remain to be defined

Cryptdin

Cryptdin-4 is a 32 amino acid amphipathic

antimicro-bial peptide that adopts a triple-stranded antiparallel

b-sheet structure constrained by three disulfide bridges

Near the MIC, cryptdin-4 induces E coli cell

permea-bilization coupled to rapid potassium efflux, a sensitive

index of cell death The lipid⁄ polydiacrylate

colorimet-ric assay and fluorescence resonance energy transfer

from the Trp of the peptide to the dansyl

chromo-phore in the membrane vesicles of various lipid

com-positions suggested that cryptdin-4 inserts deep into

the membrane of highly negatively charged

PG-con-taining or cardiolipin-conPG-con-taining vesicles and then

translocates via transient membrane defects to the

inner membrane leaflet as a consequence of closure

and disintegration of these short-lived formations [61]

Cardiolipin seems to be the key lipid constituent

con-ferring sensitivity to cryptdin-4-induced vesicle

permea-bilization Because this lipid is able to form domains

in E coli cells, it was suggested that cardiolipin

domains might serve as highly charged ‘gates’ to

facili-tate movement of cryptdin-4 into and through lipid

membranes Although these studies provide evidence

that the membrane disruptive action of cryptdin-4 is

linked to peptide translocation through lipid defects,

or pores, information on the internalization and the

fate of the peptide within microbial cells, as well as the

nature of the putative intracellular target, if any, needs

to be provided to decipher whether the microbicidal

activity of cryptdin-4 is due to its membrane

permeabi-lization⁄ disruption effect or to its ability to impede

intracellular processes

Tritrpticin

Tritrpticin consists of 13 residues and belongs to the

cathelicidin family of antimicrobial peptides from the

bone marrow of mammals Tritrpticin has a broad

spectrum of antimicrobial activity, and exhibits a high content of Trp (23%) and positively charged Arg⁄ Lys residues (31%) It adopts a well-defined amphipathic turn–turn secondary structure in a membrane-mimetic environment (organic solvents or dodecylphosphocho-line micelles [62] At high enough peptide concentra-tions, interaction of tritrpticin with membranes was postulated to cause positive curvature strain, which leads to toroidal pore formation membrane permeabili-zation and cell death in accordance with the Shai–Mat-zusaki–Huang model In contrast, TWF, in which Trp

is replaced with Phe, is highly potent against both

S aureus and E coli, but shows very little membrane-disrupting activity and no ability to depolarize the membrane potential of the microbial cell targets [9] Moreover, a lag period of about 3–6 h is required for bactericidal activity It was thus suggested that TWF-mediated cell death occurs as a result of a nonmem-branolytic mechanism, but testing of this hypothesis awaits further investigation

A closer look shows that only a small number of the above-mentioned antimicrobial peptides have been convincingly demonstrated to fulfill the criteria to be considered as microbial cell-penetrating peptides that attack internal targets in vivo, and, of these, few spon-taneously cross the cytoplasmic membrane For instance, in most cases: (a) the connection between intracellular target binding in vitro and antimicrobial activity has not been demonstrated, and⁄ or the state of integrity of the membrane has not been checked – thus, it is not known whether the microbicidal activity

of the peptides is due to their membrane permeability effect, their effects on intracellular targets, or a combi-nation of these effects; (b) although a substantial num-ber of these antimicrobial peptides have been shown to translocate through model membrane vesicles in vitro, detailed information on the internalization obtained with living cells, and quantification of peptide uptake and degradation, is still lacking – most of the confocal and electron microscopic studies reporting internaliza-tion of antimicrobial peptides have been conducted on fixed cells, and the possibility that the fixation changed the distribution of peptides cannot be ignored [63]; (c)

if intracellular targeting exists, one would expect the peptide to evoke some degree of alteration of back-ground transcript profiles, even if the peptide is present

at sublethal concentrations – this has seldom been evaluated [22,64,65]; (d) the possibility that antimicro-bial peptides interfere with the coordinated and highly dynamic functioning of membrane-bound multienzyme complexes, rather than killing through interaction with intracellular targets, has been largely ignored [22]; (e) several putative microbial cell-penetrating peptides are

synthetic analogs of naturally occurring antimicrobial

peptides that differ from the parent molecule by one

or more amino acid substitutions – as it is well known

that the microbicidal potency and selectivity of

antimi-crobial peptides, as well as their membrane-bound

structure and mode of action, are exquisitely sensitive

even to single amino acid substitutions, the penetrating

properties of the analog may not represent that of the

parent peptide; and (f) most antimicrobial peptides

that are proposed to attack internal targets exhibit an

overrepresentation of one or two amino acids, i.e Trp

and Pro, His, or Arg, hence resembling cell-penetrating

peptides (see below)

Cell-penetrating peptides working

as antimicrobial peptides, and

antimicrobial peptides working

as cell-penetrating peptides

A substantial number of mammalian cell-penetrating

peptides, including TP-10, pVEC, Tat, Pep-1, MAP,

and penetratin, have the capacity to work as

cell-pene-trating peptides or as antimicrobial peptides, the

threshold between these two properties relying on the

composition on the membrane and the peptide

concen-tration (Table 2) Their microbicidal action is thought

to be due to their ability to inhibit key intracellular

functions by crossing the microbial membrane, rather

than to create pores in the cell surface Although this

picture is accepted by most authors, because

observa-tions of translocation in model membrane systems and

in living bacteria for some cell-penetrating peptides

might support the existence of uptake mechanisms

governed by lipid-assisted pore formation, quantitative

comparison of the uptake and antimicrobial effects of

these peptides in bacteria and yeasts have

demon-strated that their uptake route, intracellular

concentra-tion, fate and microbicidal effects vary widely among

peptides and microbial organisms In several cases, the

experimental protocols that have been used suffer from

the same limitations as those mentioned above for antimicrobial peptides, preventing a clear conclusion

to be drawn about the mechanism(s) by which these peptides exert their antimicrobial action

TP-10, a 21 amino acid deletion analog of the chi-meric cell-penetrating peptide transportan, causes rapid permeabilization of S aureus cell membranes, followed

by cell entry, dispersion throughout the cytoplasm, and subsequent death of the bacteria pVEC, an 18 amino acid peptide derived from murine vascular endothelial-cadherin protein, MAP, and penetratin, has weak ability to depolarize the membrane potential

of S aureus cells and the calcein-entrapped negatively charged bacterial membrane-mimicking vesicles [66– 70] The peptides internalize within these cell lines, but all were degraded to various extents inside the cells [68,69] It was suggested that the microbial cell mem-brane permeabilization might not be the only mode of peptide uptake For instance, the import route of pVEC by B megaterium is consistent with two distinct uptake mechanisms: one operating via a transporter with high affinity and low capacity, which is sensitive

to the chirality of the peptide and reminiscent of that

of histatin-5; and another with low affinity and high capacity that could be caused by the membrane-permeabilizing activity of the peptide

Tat(47–58), an Arg-rich cell-penetrating peptide derived from the HIV-1 regulatory protein Tat, exhibits antimicrobial activity against Gram-positive and Gram-negative bacteria, and antifungal activity against Malassezia furfur, Saccharomyces cerevisiae and Tricho-sporon beigelii in the low micromolar range [71] Tat showed no ability to depolarize the membrane potential

of S aureus cells and to leak calcein-entrapped nega-tively charged lipid vesicles Tat peptide internalizes in the fungal cells and rapidly accumulates in the nucleus without causing visible damage to the cell membrane The penetration pathway of Tat is independent of energy, time, and temperature After penetration, the peptide blocks the cell cycle process of Candida albicans through arrest at G1phase

Pep-1 is a synthetic cell-penetrating peptide com-posed of an N-terminal Trp-rich domain and a C-ter-minal nuclear signal domain, KKKRKV [72], which kills E coli and Bacillus subtilis in the low micromolar range, but has low activity against Salmonella, Pseudo-monas, and Staphylococcus The peptide strongly inter-acts with negatively charged lipid bilayers, causing local perturbation and depolarization of the membrane potential, and crosses the membrane by a mechanism promoted by the transmembrane potential [73] The mechanism of translocation is controversial Deshayes

et al [74] proposed a transient

transmembrane-pore-Table 2 Amino acid sequences of designed mammalian

cell-pene-trating peptides with antimicrobial activity Hydrophobic residues

are in bold a, carboxamitaded.

like structure promoted by the a-helical conformation

of the hydrophobic domain when it interacts with

membranes This was disputed by other groups,

because no membrane leakage was observed

Conversely, the capacity to translocate across the

mammalian cell membrane has been clearly

demon-strated for some antimicrobial peptides Confocal laser

microscopy on fixed human cervical carcinoma HeLa

and fibroblastic TM12 cells, and on live Chinese

ham-ster ovary K1 cells, showed that magainin-2

permeabi-lized the cells, forming pores in the cell membrane that

allowed the entry of a large molecule

(diame-ter, > 23 nm) into the cytosol Pore formation and

subsequent cell entry are closely related to cell death

The peptide is internalized within a time scale of tens

of minutes [44,51], and once it has entered the cell,

accumulates in mitochondria and nuclei The

permea-bilization of Chinese hamster ovary cells was

accompa-nied by extensive deformation, including membrane

budding Whether magainin-2 kills mammalian cells by

dissipating membrane potential or damaging

mito-chondria is presently unknown Likewise, studies of

buforin suggest a similar ability to translocate into

mammalian cells, but by a temperature-independent,

less concentration-dependent passive mechanism, and

without showing any significant cytotoxicity [51]

These observations show that mammalian

cell-pene-trating ability and microbial cell-permeabilizing ability

can coexist within a single peptide, but the unifying

rules that govern these two properties remain to be

fully elucidated

Broadly speaking, evidence exists for two main,

simultaneous mammalian cell-entering pathways,

including direct penetration of peptides in parallel with

different forms of endocytosis, the endocytosic

path-way being a preferred form of entry of cell-penetrating

peptides, at least when attached to bioactive cargo

The direct penetration mechanism remains elusive, and

has long been thought not to involve membrane

dam-age, because no indication of membrane disruption has

been seen at relevant concentrations of peptide

How-ever, mammalian membrane disorganization associated

with penetration is very difficult to observe, because

the membrane repair response masks membrane

distur-bance by mobilizing vesicles within seconds to patch

any broken membranes [75]

Cell entry and⁄ or membrane damage may be a

common feature of some antimicrobial peptides and

cell-penetrating peptides through very similar

mecha-nisms Cell entry may involve membrane phase⁄

transient pores or long-lived transitions that can be

dependent on peptide and membrane composition

Differences in membrane lipid composition, as well as

differential lipid recruitment by peptides, may provide a basis for microbial cell killing on the one hand and mammalian cell passage on the other For instance, the translocation properties of Arg-rich cell-penetrating peptides have been shown to be directly associated with the presence of Arg residues Transmembrane crossing

of these peptides is affected by their flexibility and am-phipathicity, and is critically dependent on the number and spacing of guanidinium groups [76] In the case of Tat peptides, replacement of Arg with Lys, or with His

or ornithine, strongly reduced the translocation ability [77] Charge neutralization of the guanidinium groups through bidendate hydrogen bonding with the phos-phate groups of the bilayer is thought to be necessary for effective internalization into mammalian cells, and the efficiency of the peptide uptake is directly associated with the existence of a transmembrane potential and an appropriate balance between hydrophobicity and hydrophylic surface groups Interestingly, bidendate hydrogen bonding of the guanidinium groups of prote-grin, an Arg-rich antimicrobial peptide, with the phos-phate groups of the bilayer was demonstrated to be crucial for insertion and pore formation of the peptide within bacterial membranes [78] Molecular dynamic simulations of the Tat peptide crossing zwitterionic membranes suggest a mechanism of translocation that involves thinning of the membrane bilayers with increasing concentrations of Tat, owing to strong inter-actions between the guanidinium groups of the peptide and the phosphate groups on both sides of the mem-brane bilayers [35] This is followed by the insertion of charged side chains into the bilayer As the charged side chains enter the acyl core of the membrane, water also penetrates and solvates the charged groups, favouring the formation of a transient pore Once the pore is formed, the Tat peptide translocates across the mem-brane by diffusing on the pore walls The fast, tran-sient nature of the pore may explain why mammalian cell death because of membrane leakage was not observed with Tat [35] This mechanism is highly reminiscent of the disordered toroidal pore-electro-poration mechanism proposed for some antimicrobial peptides This suggests that general mechanisms that involve fluctuations of the membrane surface, such as transient pores and the insertion of charged side chains, may be common and central to the functions

of both cell-penetrating peptides and antimicrobial peptides

Final comments

There is a widespread acceptance that antimicrobial peptides, apart from their